Influence of Cataract Surgery on Early DME The DICAT-II Study
Study Details
Study Description
Brief Summary
To determine if cataract surgery may have an impact on the natural history of early DME (E-DME)
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Cataract surgery worsens preoperative DME, deserving an adequate pre and postoperative treatment. A large British study demonstrated that even eyes without preexisting edema are at risk of DME development after surgery according to the gravity of retinopathy. A new DME classification (the ESASO Classification of DME) defines a new category of DME, named early DME (E-DME) as follow: presence of small intraretinal cysts associated with well-recognizable and detectable inner retinal layers, ellipsoid zone (EZ) and external limiting membrane (ELM), with increase in central subfield thickness (CST) and/or macular volume (MV) less than 30% of maximum normal values.
Due to its undetectable or minimal impact on visual function, E-DME has not yet been studied, and retinologists usually restrict treatment to more advanced cases.
E-DME is the most frequent type of DME among the population undergoing cataract surgery, estimated by DICAT-I Study in 20.7% of the diabetic subjects, corresponding to 5.4% of the general population.
It has been demonstrated that cataract surgery has a negative impact both on diabetic eyes with no DME and in eyes with advanced DME. Even E-DME therefore probably worsens after surgery but there are no data on this matter.
Study Objective: to determine if cataract surgery may have an impact on the natural history of early DME (E-DME) Study Design: prospective multi-center observational case-control study
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| SURGERY subjects with early DME undergoing cataract surgery |
Procedure: cataract surgery
phacoemulsification
|
| OBSERVATION subjects with early DME |
Outcome Measures
Primary Outcome Measures
- Influence of cataract surgery on E-DME [4 months]
Changes in central subfield thickness (CST) and/or macular volume (MV) measured by SD-OCT in eyes with E-DME during the first 4 months after cataract surgery (Group 1) compared to eyes with the same condition but without any surgical intervention (Group 2). Eyes in both groups developing a "significant worsening" of E-DME, defined as an increase of at least 50 microns in central subfield thickness (CST) or 0.5 mm3 in macular volume (MV) measured by SD-OCT will be withdrawn from the study to receive adequate therapeutic intervention.
Eligibility Criteria
Criteria
Inclusion Criteria:
Eligible patients will be identified during the regular preoperative cataract examination. In the presence of a diabetic patient, an OCT scan will be performed (according to the protocol, see below).
Only eyes with E-DME will be eligible for the study.
Inclusion criteria may be one of the following:
-
Diabetic patients with bilateral E-DME and bilateral cataract. Both eyes will be enrolled: one eye will receive surgery at M4, the other at the end of follow up (M8) or later (gold candidate).
-
Diabetic patients with bilateral E-DME and cataract in just one eye (gold candidate). The eye with E-DME and no cataract may be already pseudophakic (surgery performed at least 18 months before) or with clear media.
-
Diabetic patients with E-DME and cataract in just one eye
-
Diabetic patients with cataract and no E-DME in the eye scheduled for surgery but E-DME in the other eye. Only the eye with E-DME will be enrolled.
Exclusion Criteria:
-
Past ocular surgery of any kind (except for cataract surgery) or ocular pathologies other than diabetic retinopathy.
-
Macular edema considered to be due to a cause other than diabetic macular edema.
-
OCT examination suggesting that vitreoretinal interface abnormalities (e.g., a taut posterior hyaloid or epiretinal membrane) are the primary cause of the macular edema. In the case of ERM, an OCT scan must be sent to the Coordinating Center for approval.
-
Any ocular pathology or ocular condition is present (other than diabetes) that, in the opinion of the investigator, might affect macular edema
-
History of any therapy (anti-VEGF treatment, focal/grid macular photocoagulation, intravitreous or peribulbar corticosteroids) for DME or diabetic retinopathy in the past 12 months.
-
History of YAG capsulotomy performed within two months before enrollment.
-
Aphakia.
-
Evidence of uncontrolled glaucoma.
-
Intraocular pressure must be <25 mmHg, with no more than one topical glaucoma medication.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | ESASO Scientific Projects | Lugano | Switzerland | CH-6901 |
Sponsors and Collaborators
- European School of Advanced Studies in Ophthalmology
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- DICAT-II